Anthem Biosciences IPO GMP: The IPO attracted strong interest, receiving bids for 17.66 crore shares against 4.4 crore shares on offer. Non-institutional investors (NIIs) led the demand, subscribing 12.37 times their allotted quota. The retail segment saw 2.38 times subscription, while qualified institutional buyers (QIBs) subscribed to 60% of their portion.
Wait for dust to settle before taking fresh bets, says Maulik Patel
Geopolitical tensions and market swings prompt caution for investors. Maulik Patel of Equirus Securities advises patience, suggesting a wait-and-watch approach. He notes current crises differ